NEW YORK (GenomeWeb News) - Acacia Research said yesterday that it has received commitments for the purchase of $5 million in Acacia Research-CombiMatrix common stock and warrants through a direct offering that includes several CombiMatrix executives. 
 
Acacia plans to sell 6.8 million units at $.738 per share to "a select group of investors" including CombiMatrix President and CEO Amit Kumar and company directors Tom Akin and John Abeles.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.